GILEAD SCIENCES, INC. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
GILEAD SCIENCES, INC. (GILD) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $1.75 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2026-08-06
- GILEAD SCIENCES, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2026-06-30 was $1.75B, a 821.05% increase year-over-year.
- GILEAD SCIENCES, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-12-31 was $400.00M.
- GILEAD SCIENCES, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- GILEAD SCIENCES, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-06-30 was $190.00M.
- GILEAD SCIENCES, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2025 was $590.00M, a 85.89% decline from fiscal 2024.
- GILEAD SCIENCES, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2024 was $4.18B, a 8260.00% increase from fiscal 2023.
- GILEAD SCIENCES, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2023 was $50.00M, a 98.15% decline from fiscal 2022.
- GILEAD SCIENCES, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2022 was $2.70B.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.75B 10-Q · filed 2026-08-06 | $1.75B 10-Q · filed 2026-08-06 | ||
| 2025-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $400.00M derived: sum of 2 quarters · filed 2026-02-24 | $590.00M derived: sum of 3 quarters · filed 2026-08-06 | $590.00M 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | $190.00M derived: sum of 2 quarters · filed 2026-08-06 | $190.00M 10-Q · filed 2025-11-07 | $190.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $190.00M 10-Q · filed 2026-08-06 | $190.00M 10-Q · filed 2026-08-06 | $190.00M derived: sum of 3 quarters · filed 2026-08-06 | $1.94B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $1.75B derived: sum of 3 quarters · filed 2026-02-24 | $1.75B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.75B derived: sum of 2 quarters · filed 2026-02-24 | $1.75B derived: sum of 3 quarters · filed 2026-02-24 | $4.18B 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.75B 10-Q · filed 2025-11-07 | $1.75B derived: sum of 2 quarters · filed 2025-11-07 | $4.18B 10-Q · filed 2025-11-07 | $4.23B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $2.43B 10-Q · filed 2025-08-07 | $2.48B derived: sum of 3 quarters · filed 2026-02-24 | $2.48B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $2.43B 10-Q · filed 2025-05-07 | $2.48B derived: sum of 2 quarters · filed 2026-02-24 | $2.48B derived: sum of 3 quarters · filed 2026-02-24 | $2.48B derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $50.00M derived: sum of 2 quarters · filed 2026-02-24 | $50.00M derived: sum of 3 quarters · filed 2026-02-24 | $50.00M 10-K · filed 2026-02-24 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $2.70B 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $2.70B 10-Q · filed 2023-11-07 | $2.70B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $2.70B 10-Q · filed 2023-08-04 | $2.70B derived: sum of 3 quarters · filed 2024-02-23 | $2.70B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $2.70B 10-Q · filed 2023-05-03 | $2.70B derived: sum of 2 quarters · filed 2024-02-23 | $2.70B derived: sum of 3 quarters · filed 2024-02-23 | $2.70B derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | $0.00 derived: sum of 3 quarters · filed 2024-02-23 | $0.00 10-K · filed 2024-02-23 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-22 | |||
| 2019-12-31 | $800.00M 10-K · filed 2021-02-25 | $800.00M 10-K · filed 2022-02-23 | ||
| 2018-12-31 | $820.00M 10-K · filed 2020-02-25 | $820.00M 10-K · filed 2021-02-25 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $201.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 | $201.00M derived: sum of 3 quarters · filed 2019-02-26 | $318.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $201.00M derived: sum of 2 quarters · filed 2019-02-26 | $318.00M derived: sum of 3 quarters · filed 2019-02-26 | $318.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $201.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $318.00M derived: sum of 2 quarters · filed 2019-02-26 | $318.00M derived: sum of 3 quarters · filed 2019-02-26 | $432.00M 10-K · filed 2019-02-26 |
| 2016-09-30 | $117.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $117.00M derived: sum of 2 quarters · filed 2017-11-07 | $231.00M 10-Q · filed 2017-11-07 | $231.00M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $114.00M 10-Q · filed 2017-08-07 | $114.00M derived: sum of 3 quarters · filed 2018-02-27 | $114.00M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $114.00M 10-Q · filed 2017-05-10 | $114.00M derived: sum of 2 quarters · filed 2018-02-27 | $114.00M derived: sum of 3 quarters · filed 2018-02-27 | $114.00M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $0.00 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-06 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-27 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-02-25 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-02-25 | |||
| 2011-12-31 | $26.63M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |